Salix Pharmaceuticals Ltd
Q4 2014 13F Holders
Symbol
SLXP
CUSIP
795435106
Type
Equity
Class
COM
Num filings
391
Total reported value, excl. options
$8.08 B
Compare 2014 Q4 to
2016 Q1
2015 Q4
2015 Q2
2015 Q1
2014 Q3
2014 Q2
2014 Q1
Manager
Report Date
Value ($000)
Shares
Option Type